Magazine Article | January 9, 2018

Classifying Independent Contractors: 3 Things Pharma CEOs Should Know

Source: Life Science Leader

By Rebecca Cenni

Pharmaceutical companies abide by strict regulations and ensure compliance during drug development and manufacturing, but when it comes to regulations surrounding employment, it’s imperative to exercise the same level of care. Not unlike a clinical trial setback, misclassification of independent contractors (ICs) can have a substantial negative impact on the business. Here are three key IC considerations pharma execs should ensure are addressed by compliance efforts.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: